QUICKLINKS AND VIEW OPITONS
Belviq (lorcaserin) may cause disturbances in attention or memory
Wednesday, June 27, 2012 10:35 am Email this article
"Belviq [lorcaserin hydrochloride] may also cause disturbances in attention or memory," according to the Press Release from the U.S. Food and Drug Administration. The drug was approved by the FDA on June 27, 2012.
Fda. Fda approves belviq [lorcaserin hydrochloride] to treat some overweight or obese adults. FDA News Press Release. 2012 Jun 27,
Articles on the same subject can be found here:
Please feel free to share your comments about this article.
© Copyright 2003-2017 - Larry Hobbs - All Rights Reserved.